Home › Funds › JOHNSON & JOHNSON › NMRA

JOHNSON & JOHNSON position in NMRA

NEUMORA THERAPEUTICS INC. · Health Care

JOHNSON & JOHNSON reported holding 1,849,445 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.14% of its reported portfolio and ranking #12 among its reported holdings. JOHNSON & JOHNSON has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.85M sh
Reported value held$1.10M
Portfolio Weight0.14%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JOHNSON & JOHNSON's NMRA position evolved

JOHNSON & JOHNSON first disclosed a stake in NMRA in Q3 2023 at 912,128 shares (US$12.9M). The position peaked in Q4 2023 at 1,849,445 shares, worth US$31.5M. Across 13 filings, JOHNSON & JOHNSON increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 1,849,445 shares valued at US$1.1M. Notable position changes include a 103% increase in Q4 2023 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 912.13K $12.87M New
Q4 2023 1.85M $31.53M Add
Q1 2024 1.85M $25.43M Hold
Q2 2024 1.85M $18.18M Hold
Q3 2024 1.85M $24.43M Hold
Q4 2024 1.85M $19.60M Hold
Q1 2025 1.85M $1.85M Hold
Q2 2025 1.85M $1.40M Hold
Q3 2025 1.85M $3.37M Hold
Q4 2025 1.85M $3.31M Hold
Q1 2026 1.85M $3.61M Hold
Q2 2026 1.85M $3.14M Hold
Q3 2026 1.85M $1.10M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NMRA and 13F data

NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 18 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), ICONIQ Capital, LLC (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NMRA

All NMRA fund holders →

FAQ

How long has JOHNSON & JOHNSON held NMRA?

JOHNSON & JOHNSON has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JOHNSON & JOHNSON's current position in NMRA?

As of Q3 2026, JOHNSON & JOHNSON holds 1.85M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.10M, representing 0.14% of its reported portfolio and ranking #12.

Has JOHNSON & JOHNSON been buying or selling NMRA?

In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in NMRA. The position peaked in Q4 2023 at 1.85M shares.

Which other funds hold NMRA?

Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, ICONIQ Capital, LLC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.